Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 365-371
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 49
Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population
Stefano Ciardullo, Alice Oltolini, Rosa Cannistraci, et al.
American Journal of Clinical Nutrition (2022) Vol. 115, Iss. 6, pp. 1528-1534
Open Access | Times Cited: 44
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
Cheng Han Ng, Zhen Yu Wong, Nicholas Chew, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 42
Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies
Gerui Li, Yuanyuan Peng, Ze Chen, et al.
International Journal of Endocrinology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 34
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
Stefano Ciardullo, Gianluca Perseghin
Diabetes Research and Clinical Practice (2022) Vol. 190, pp. 109981-109981
Closed Access | Times Cited: 33
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
Jieling Xiao, Cheng Han Ng, Kai En Chan, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 4, pp. 656-665
Open Access | Times Cited: 31
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 968-968
Open Access | Times Cited: 28
Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis
Stefano Ciardullo, Emanuele Muraca, Rosa Cannistraci, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 5
Open Access | Times Cited: 16
Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers
Aya Hirata, Sei Harada, Miho Iida, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 7, pp. 1031-1047
Open Access | Times Cited: 7
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Clinical and Experimental Hypertension (2025) Vol. 47, Iss. 1
Open Access
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study
Zhi Liu, He He, Yuzhao Dai, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Shared Mechanisms between Cardiovascular Disease and NAFLD
Daniel Q. Huang, Michael Downes, Ronald M. Evans, et al.
Seminars in Liver Disease (2022) Vol. 42, Iss. 04, pp. 455-464
Open Access | Times Cited: 23
Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes
Yansong Lin, Xiongcai Feng, Xu Cao, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 15
Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease
Run Zhou, Yunpeng Gu, Binbin Zhang, et al.
Clinical and Translational Gastroenterology (2023)
Open Access | Times Cited: 12
Rationale for choosing antihypertensive therapy in a patient with NAFLD and arterial hypertension
С. Н. Мехтиев, O. A. Mekhtiyeva, O. M. Berko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 86-95
Closed Access
Mediation analyses link cardiometabolic factors and liver fat with white matter hyperintensities and cognitive performance: A UK Biobank study
Daniel E. Askeland-Gjerde, Lars T. Westlye, Patrik Andersson, et al.
Biological Psychiatry Global Open Science (2025), pp. 100488-100488
Open Access
Renal Sinus Fat Is Expanded in Patients with Obesity and/or Hypertension and Reduced by Bariatric Surgery Associated with Hypertension Remission
Emilia Moritz, Prince Dadson, Ekaterina Saukko, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 617-617
Open Access | Times Cited: 21
Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Luping Wang, Bowen Sang, Zuyan Zheng
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 20
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
Qian Hu, Yao Chen, Ting Bao, et al.
Renal Failure (2022) Vol. 44, Iss. 1, pp. 2006-2015
Open Access | Times Cited: 13
Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
Zhaoxiang Wang, Zhicong Zhao, Yue Xia, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 7, pp. 1379-1392
Closed Access | Times Cited: 12
Association between hypertension and the prevalence of liver steatosis and fibrosis
Huanjie Fu, Hao Yu, Yisheng Zhao, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Atherosclerosis and Non-Alcoholic Fatty Liver Disease
Şevket Balta
Angiology (2022) Vol. 73, Iss. 8, pp. 701-711
Closed Access | Times Cited: 11
Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes
Yilian Xie, Weiliang Kong, Xuepeng Wang, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top